Chris WoodAIThe paradox of AI in lung nodulesIn this column, RevealDx CEO Chris Wood describes a pathway to reducing lung cancer mortality that isn't being fully utilized in the U.S.November 24, 2025Page 1 of 1Top StoriesInterventionalSclerotherapy spares ovarian reserve without loss of therapeutic efficacyThe results offer evidence that supports sclerotherapy as an ovary-sparing alternative to surgery for selected patients.Practice ManagementTechnologist aides may support IR procedures amid staffing shortagesRisk ManagementCan AI reduce malpractice risk for radiologists?Womens ImagingTailoring breast radiotherapy to women's risk leads to successSponsor ContentModernizing Radiotherapy Workflows
